Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Anti-Malarial Drug Market Growth 2022-2028

  • LP 4808850
  • 103 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Anti-Malarial Drug will have significant change from previous year. According to our (LP Information) latest study, the global Anti-Malarial Drug market size is USD million in 2022 from USD 667.7 million in 2021, with a change of % between 2021 and 2022. The global Anti-Malarial Drug market size will reach USD 804 million in 2028, growing at a CAGR of 2.7% over the analysis period.

The United States Anti-Malarial Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Anti-Malarial Drug market, reaching US$ million by the year 2028. As for the Europe Anti-Malarial Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Anti-Malarial Drug players cover GlaxoSmithKline, Ranbaxy, Zydus Cadila, and Alvizia, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Malarial Drug market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Plasmodium Falciparum

Plasmodium Vivax

Plasmodium Malariae

Plasmodium Ovale

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital Pharmacy

Retail Pharmacy

E-Commerce

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

GlaxoSmithKline

Ranbaxy

Zydus Cadila

Alvizia

Bayer

Ipca

Merck

F. Hoffmann-La Roche

Novartis

Pfizer

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Anti-Malarial Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Anti-Malarial Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Anti-Malarial Drug by Country/Region, 2017, 2022 & 2028

2.2 Anti-Malarial Drug Segment by Type

2.2.1 Plasmodium Falciparum

2.2.2 Plasmodium Vivax

2.2.3 Plasmodium Malariae

2.2.4 Plasmodium Ovale

2.3 Anti-Malarial Drug Sales by Type

2.3.1 Global Anti-Malarial Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Anti-Malarial Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Anti-Malarial Drug Sale Price by Type (2017-2022)

2.4 Anti-Malarial Drug Segment by Application

2.4.1 Hospital Pharmacy

2.4.2 Retail Pharmacy

2.4.3 E-Commerce

2.4.4 Others

2.5 Anti-Malarial Drug Sales by Application

2.5.1 Global Anti-Malarial Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Anti-Malarial Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Anti-Malarial Drug Sale Price by Application (2017-2022)

3 Global Anti-Malarial Drug by Company

3.1 Global Anti-Malarial Drug Breakdown Data by Company

3.1.1 Global Anti-Malarial Drug Annual Sales by Company (2020-2022)

3.1.2 Global Anti-Malarial Drug Sales Market Share by Company (2020-2022)

3.2 Global Anti-Malarial Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Anti-Malarial Drug Revenue by Company (2020-2022)

3.2.2 Global Anti-Malarial Drug Revenue Market Share by Company (2020-2022)

3.3 Global Anti-Malarial Drug Sale Price by Company

3.4 Key Manufacturers Anti-Malarial Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Anti-Malarial Drug Product Location Distribution

3.4.2 Players Anti-Malarial Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Anti-Malarial Drug by Geographic Region

4.1 World Historic Anti-Malarial Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Anti-Malarial Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Anti-Malarial Drug Annual Revenue by Geographic Region

4.2 World Historic Anti-Malarial Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Anti-Malarial Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Anti-Malarial Drug Annual Revenue by Country/Region

4.3 Americas Anti-Malarial Drug Sales Growth

4.4 APAC Anti-Malarial Drug Sales Growth

4.5 Europe Anti-Malarial Drug Sales Growth

4.6 Middle East & Africa Anti-Malarial Drug Sales Growth

5 Americas

5.1 Americas Anti-Malarial Drug Sales by Country

5.1.1 Americas Anti-Malarial Drug Sales by Country (2017-2022)

5.1.2 Americas Anti-Malarial Drug Revenue by Country (2017-2022)

5.2 Americas Anti-Malarial Drug Sales by Type

5.3 Americas Anti-Malarial Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Anti-Malarial Drug Sales by Region

6.1.1 APAC Anti-Malarial Drug Sales by Region (2017-2022)

6.1.2 APAC Anti-Malarial Drug Revenue by Region (2017-2022)

6.2 APAC Anti-Malarial Drug Sales by Type

6.3 APAC Anti-Malarial Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Anti-Malarial Drug by Country

7.1.1 Europe Anti-Malarial Drug Sales by Country (2017-2022)

7.1.2 Europe Anti-Malarial Drug Revenue by Country (2017-2022)

7.2 Europe Anti-Malarial Drug Sales by Type

7.3 Europe Anti-Malarial Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Anti-Malarial Drug by Country

8.1.1 Middle East & Africa Anti-Malarial Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Anti-Malarial Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Anti-Malarial Drug Sales by Type

8.3 Middle East & Africa Anti-Malarial Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Anti-Malarial Drug

10.3 Manufacturing Process Analysis of Anti-Malarial Drug

10.4 Industry Chain Structure of Anti-Malarial Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Anti-Malarial Drug Distributors

11.3 Anti-Malarial Drug Customer

12 World Forecast Review for Anti-Malarial Drug by Geographic Region

12.1 Global Anti-Malarial Drug Market Size Forecast by Region

12.1.1 Global Anti-Malarial Drug Forecast by Region (2023-2028)

12.1.2 Global Anti-Malarial Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Anti-Malarial Drug Forecast by Type

12.7 Global Anti-Malarial Drug Forecast by Application

13 Key Players Analysis

13.1 GlaxoSmithKline

13.1.1 GlaxoSmithKline Company Information

13.1.2 GlaxoSmithKline Anti-Malarial Drug Product Offered

13.1.3 GlaxoSmithKline Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 GlaxoSmithKline Main Business Overview

13.1.5 GlaxoSmithKline Latest Developments

13.2 Ranbaxy

13.2.1 Ranbaxy Company Information

13.2.2 Ranbaxy Anti-Malarial Drug Product Offered

13.2.3 Ranbaxy Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Ranbaxy Main Business Overview

13.2.5 Ranbaxy Latest Developments

13.3 Zydus Cadila

13.3.1 Zydus Cadila Company Information

13.3.2 Zydus Cadila Anti-Malarial Drug Product Offered

13.3.3 Zydus Cadila Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Zydus Cadila Main Business Overview

13.3.5 Zydus Cadila Latest Developments

13.4 Alvizia

13.4.1 Alvizia Company Information

13.4.2 Alvizia Anti-Malarial Drug Product Offered

13.4.3 Alvizia Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Alvizia Main Business Overview

13.4.5 Alvizia Latest Developments

13.5 Bayer

13.5.1 Bayer Company Information

13.5.2 Bayer Anti-Malarial Drug Product Offered

13.5.3 Bayer Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Bayer Main Business Overview

13.5.5 Bayer Latest Developments

13.6 Ipca

13.6.1 Ipca Company Information

13.6.2 Ipca Anti-Malarial Drug Product Offered

13.6.3 Ipca Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Ipca Main Business Overview

13.6.5 Ipca Latest Developments

13.7 Merck

13.7.1 Merck Company Information

13.7.2 Merck Anti-Malarial Drug Product Offered

13.7.3 Merck Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Merck Main Business Overview

13.7.5 Merck Latest Developments

13.8 F. Hoffmann-La Roche

13.8.1 F. Hoffmann-La Roche Company Information

13.8.2 F. Hoffmann-La Roche Anti-Malarial Drug Product Offered

13.8.3 F. Hoffmann-La Roche Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 F. Hoffmann-La Roche Main Business Overview

13.8.5 F. Hoffmann-La Roche Latest Developments

13.9 Novartis

13.9.1 Novartis Company Information

13.9.2 Novartis Anti-Malarial Drug Product Offered

13.9.3 Novartis Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Novartis Main Business Overview

13.9.5 Novartis Latest Developments

13.10 Pfizer

13.10.1 Pfizer Company Information

13.10.2 Pfizer Anti-Malarial Drug Product Offered

13.10.3 Pfizer Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Pfizer Main Business Overview

13.10.5 Pfizer Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Anti-Malarial Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Anti-Malarial Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Plasmodium Falciparum

Table 4. Major Players of Plasmodium Vivax

Table 5. Major Players of Plasmodium Malariae

Table 6. Major Players of Plasmodium Ovale

Table 7. Global Anti-Malarial Drug Sales by Type (2017-2022) & (MT)

Table 8. Global Anti-Malarial Drug Sales Market Share by Type (2017-2022)

Table 9. Global Anti-Malarial Drug Revenue by Type (2017-2022) & ($ million)

Table 10. Global Anti-Malarial Drug Revenue Market Share by Type (2017-2022)

Table 11. Global Anti-Malarial Drug Sale Price by Type (2017-2022) & (USD/Kg)

Table 12. Global Anti-Malarial Drug Sales by Application (2017-2022) & (MT)

Table 13. Global Anti-Malarial Drug Sales Market Share by Application (2017-2022)

Table 14. Global Anti-Malarial Drug Revenue by Application (2017-2022)

Table 15. Global Anti-Malarial Drug Revenue Market Share by Application (2017-2022)

Table 16. Global Anti-Malarial Drug Sale Price by Application (2017-2022) & (USD/Kg)

Table 17. Global Anti-Malarial Drug Sales by Company (2020-2022) & (MT)

Table 18. Global Anti-Malarial Drug Sales Market Share by Company (2020-2022)

Table 19. Global Anti-Malarial Drug Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Anti-Malarial Drug Revenue Market Share by Company (2020-2022)

Table 21. Global Anti-Malarial Drug Sale Price by Company (2020-2022) & (USD/Kg)

Table 22. Key Manufacturers Anti-Malarial Drug Producing Area Distribution and Sales Area

Table 23. Players Anti-Malarial Drug Products Offered

Table 24. Anti-Malarial Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Anti-Malarial Drug Sales by Geographic Region (2017-2022) & (MT)

Table 28. Global Anti-Malarial Drug Sales Market Share Geographic Region (2017-2022)

Table 29. Global Anti-Malarial Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Anti-Malarial Drug Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Anti-Malarial Drug Sales by Country/Region (2017-2022) & (MT)

Table 32. Global Anti-Malarial Drug Sales Market Share by Country/Region (2017-2022)

Table 33. Global Anti-Malarial Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Anti-Malarial Drug Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Anti-Malarial Drug Sales by Country (2017-2022) & (MT)

Table 36. Americas Anti-Malarial Drug Sales Market Share by Country (2017-2022)

Table 37. Americas Anti-Malarial Drug Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Anti-Malarial Drug Revenue Market Share by Country (2017-2022)

Table 39. Americas Anti-Malarial Drug Sales by Type (2017-2022) & (MT)

Table 40. Americas Anti-Malarial Drug Sales Market Share by Type (2017-2022)

Table 41. Americas Anti-Malarial Drug Sales by Application (2017-2022) & (MT)

Table 42. Americas Anti-Malarial Drug Sales Market Share by Application (2017-2022)

Table 43. APAC Anti-Malarial Drug Sales by Region (2017-2022) & (MT)

Table 44. APAC Anti-Malarial Drug Sales Market Share by Region (2017-2022)

Table 45. APAC Anti-Malarial Drug Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Anti-Malarial Drug Revenue Market Share by Region (2017-2022)

Table 47. APAC Anti-Malarial Drug Sales by Type (2017-2022) & (MT)

Table 48. APAC Anti-Malarial Drug Sales Market Share by Type (2017-2022)

Table 49. APAC Anti-Malarial Drug Sales by Application (2017-2022) & (MT)

Table 50. APAC Anti-Malarial Drug Sales Market Share by Application (2017-2022)

Table 51. Europe Anti-Malarial Drug Sales by Country (2017-2022) & (MT)

Table 52. Europe Anti-Malarial Drug Sales Market Share by Country (2017-2022)

Table 53. Europe Anti-Malarial Drug Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Anti-Malarial Drug Revenue Market Share by Country (2017-2022)

Table 55. Europe Anti-Malarial Drug Sales by Type (2017-2022) & (MT)

Table 56. Europe Anti-Malarial Drug Sales Market Share by Type (2017-2022)

Table 57. Europe Anti-Malarial Drug Sales by Application (2017-2022) & (MT)

Table 58. Europe Anti-Malarial Drug Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Anti-Malarial Drug Sales by Country (2017-2022) & (MT)

Table 60. Middle East & Africa Anti-Malarial Drug Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Anti-Malarial Drug Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Anti-Malarial Drug Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Anti-Malarial Drug Sales by Type (2017-2022) & (MT)

Table 64. Middle East & Africa Anti-Malarial Drug Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Anti-Malarial Drug Sales by Application (2017-2022) & (MT)

Table 66. Middle East & Africa Anti-Malarial Drug Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Anti-Malarial Drug

Table 68. Key Market Challenges & Risks of Anti-Malarial Drug

Table 69. Key Industry Trends of Anti-Malarial Drug

Table 70. Anti-Malarial Drug Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Anti-Malarial Drug Distributors List

Table 73. Anti-Malarial Drug Customer List

Table 74. Global Anti-Malarial Drug Sales Forecast by Region (2023-2028) & (MT)

Table 75. Global Anti-Malarial Drug Sales Market Forecast by Region

Table 76. Global Anti-Malarial Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Anti-Malarial Drug Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Anti-Malarial Drug Sales Forecast by Country (2023-2028) & (MT)

Table 79. Americas Anti-Malarial Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Anti-Malarial Drug Sales Forecast by Region (2023-2028) & (MT)

Table 81. APAC Anti-Malarial Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Anti-Malarial Drug Sales Forecast by Country (2023-2028) & (MT)

Table 83. Europe Anti-Malarial Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Anti-Malarial Drug Sales Forecast by Country (2023-2028) & (MT)

Table 85. Middle East & Africa Anti-Malarial Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Anti-Malarial Drug Sales Forecast by Type (2023-2028) & (MT)

Table 87. Global Anti-Malarial Drug Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Anti-Malarial Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Anti-Malarial Drug Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Anti-Malarial Drug Sales Forecast by Application (2023-2028) & (MT)

Table 91. Global Anti-Malarial Drug Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Anti-Malarial Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Anti-Malarial Drug Revenue Market Share Forecast by Application (2023-2028)

Table 94. GlaxoSmithKline Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors

Table 95. GlaxoSmithKline Anti-Malarial Drug Product Offered

Table 96. GlaxoSmithKline Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 97. GlaxoSmithKline Main Business

Table 98. GlaxoSmithKline Latest Developments

Table 99. Ranbaxy Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors

Table 100. Ranbaxy Anti-Malarial Drug Product Offered

Table 101. Ranbaxy Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 102. Ranbaxy Main Business

Table 103. Ranbaxy Latest Developments

Table 104. Zydus Cadila Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors

Table 105. Zydus Cadila Anti-Malarial Drug Product Offered

Table 106. Zydus Cadila Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 107. Zydus Cadila Main Business

Table 108. Zydus Cadila Latest Developments

Table 109. Alvizia Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors

Table 110. Alvizia Anti-Malarial Drug Product Offered

Table 111. Alvizia Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 112. Alvizia Main Business

Table 113. Alvizia Latest Developments

Table 114. Bayer Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors

Table 115. Bayer Anti-Malarial Drug Product Offered

Table 116. Bayer Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 117. Bayer Main Business

Table 118. Bayer Latest Developments

Table 119. Ipca Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors

Table 120. Ipca Anti-Malarial Drug Product Offered

Table 121. Ipca Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 122. Ipca Main Business

Table 123. Ipca Latest Developments

Table 124. Merck Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors

Table 125. Merck Anti-Malarial Drug Product Offered

Table 126. Merck Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 127. Merck Main Business

Table 128. Merck Latest Developments

Table 129. F. Hoffmann-La Roche Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors

Table 130. F. Hoffmann-La Roche Anti-Malarial Drug Product Offered

Table 131. F. Hoffmann-La Roche Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 132. F. Hoffmann-La Roche Main Business

Table 133. F. Hoffmann-La Roche Latest Developments

Table 134. Novartis Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors

Table 135. Novartis Anti-Malarial Drug Product Offered

Table 136. Novartis Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 137. Novartis Main Business

Table 138. Novartis Latest Developments

Table 139. Pfizer Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors

Table 140. Pfizer Anti-Malarial Drug Product Offered

Table 141. Pfizer Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 142. Pfizer Main Business

Table 143. Pfizer Latest Developments

List of Figures

Figure 1. Picture of Anti-Malarial Drug

Figure 2. Anti-Malarial Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Anti-Malarial Drug Sales Growth Rate 2017-2028 (MT)

Figure 7. Global Anti-Malarial Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Anti-Malarial Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Plasmodium Falciparum

Figure 10. Product Picture of Plasmodium Vivax

Figure 11. Product Picture of Plasmodium Malariae

Figure 12. Product Picture of Plasmodium Ovale

Figure 13. Global Anti-Malarial Drug Sales Market Share by Type in 2021

Figure 14. Global Anti-Malarial Drug Revenue Market Share by Type (2017-2022)

Figure 15. Anti-Malarial Drug Consumed in Hospital Pharmacy

Figure 16. Global Anti-Malarial Drug Market: Hospital Pharmacy (2017-2022) & (MT)

Figure 17. Anti-Malarial Drug Consumed in Retail Pharmacy

Figure 18. Global Anti-Malarial Drug Market: Retail Pharmacy (2017-2022) & (MT)

Figure 19. Anti-Malarial Drug Consumed in E-Commerce

Figure 20. Global Anti-Malarial Drug Market: E-Commerce (2017-2022) & (MT)

Figure 21. Anti-Malarial Drug Consumed in Others

Figure 22. Global Anti-Malarial Drug Market: Others (2017-2022) & (MT)

Figure 23. Global Anti-Malarial Drug Sales Market Share by Application (2017-2022)

Figure 24. Global Anti-Malarial Drug Revenue Market Share by Application in 2021

Figure 25. Anti-Malarial Drug Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Anti-Malarial Drug Revenue Market Share by Company in 2021

Figure 27. Global Anti-Malarial Drug Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Anti-Malarial Drug Revenue Market Share by Geographic Region in 2021

Figure 29. Global Anti-Malarial Drug Sales Market Share by Region (2017-2022)

Figure 30. Global Anti-Malarial Drug Revenue Market Share by Country/Region in 2021

Figure 31. Americas Anti-Malarial Drug Sales 2017-2022 (MT)

Figure 32. Americas Anti-Malarial Drug Revenue 2017-2022 ($ Millions)

Figure 33. APAC Anti-Malarial Drug Sales 2017-2022 (MT)

Figure 34. APAC Anti-Malarial Drug Revenue 2017-2022 ($ Millions)

Figure 35. Europe Anti-Malarial Drug Sales 2017-2022 (MT)

Figure 36. Europe Anti-Malarial Drug Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Anti-Malarial Drug Sales 2017-2022 (MT)

Figure 38. Middle East & Africa Anti-Malarial Drug Revenue 2017-2022 ($ Millions)

Figure 39. Americas Anti-Malarial Drug Sales Market Share by Country in 2021

Figure 40. Americas Anti-Malarial Drug Revenue Market Share by Country in 2021

Figure 41. United States Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Anti-Malarial Drug Sales Market Share by Region in 2021

Figure 46. APAC Anti-Malarial Drug Revenue Market Share by Regions in 2021

Figure 47. China Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Anti-Malarial Drug Sales Market Share by Country in 2021

Figure 54. Europe Anti-Malarial Drug Revenue Market Share by Country in 2021

Figure 55. Germany Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Anti-Malarial Drug Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Anti-Malarial Drug Revenue Market Share by Country in 2021

Figure 62. Egypt Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Anti-Malarial Drug Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Anti-Malarial Drug in 2021

Figure 68. Manufacturing Process Analysis of Anti-Malarial Drug

Figure 69. Industry Chain Structure of Anti-Malarial Drug

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390